AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ARMP
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in Armata Pharmaceuticals Inc. stock price on Wednesday which ended trading at $2.58
(Updated on May 22, 2024)

Sell candidate since May 14, 2024 Loss -11.64% PDF

The Armata Pharmaceuticals Inc. stock price gained 0.389% on the last trading day (Wednesday, 22nd May 2024), rising from $2.57 to $2.58. During the last trading day the stock fluctuated 11.28% from a day low at $2.57 to a day high of $2.86. The price has fallen in 5 of the last 10 days and is down by -6.52% for this period. Volume fell on the last day by -891 shares and in total, 17 thousand shares were bought and sold for approximately $44.67 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -29.14% during the next 3 months and, with a 90% probability hold a price between $1.47 and $2.37 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ARMP Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, May 01, 2024, and so far it has risen 7.50%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Armata Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.63 and $2.87. A break-up above any of these levels will issue buy signals. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Armata Pharmaceuticals Inc. stock

Armata Pharmaceuticals Inc. finds support from accumulated volume at $2.55 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.290 between high and low, or 11.28%. For the last week the stock has had daily average volatility of 18.19%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ARMP) For The Upcoming Trading Day Of Thursday 23rd

For the upcoming trading day on Thursday, 23rd we expect Armata Pharmaceuticals Inc. to open at $2.67, and during the day (based on 14 day Average True Range), to move between $2.20 and $2.96, which gives a possible trading interval of +/-$0.379 (+/-14.69%) up or down from last closing price. If Armata Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 29.38% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.59 (0.39%) than the support at $2.55 (1.16%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Armata Pharmaceuticals Inc. stock A Buy?

Armata Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.479 Sell Candidate Unchanged

Predicted Opening Price for Armata Pharmaceuticals Inc. of Thursday, May 23, 2024

Fair opening price May 23, 2024 Current price
$2.67 ( 3.49%) $2.58

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ARMP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.96 14.73 %
R2 2.85 10.43 %
R1 2.78 7.78 %
Current price: 2.58
Support S1 2.56 -0.81 %
S2 2.49 -3.46 %
S3 2.38 -7.75 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.86 10.85 %
R2 2.65 2.71 %
R1 2.59 0.388 %
Current price 2.58
Support S1 2.55 -1.16%
S2 2.50 -3.10%
S3 2.48 -3.88%

FAQ

What is the symbol for Armata Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for Armata Pharmaceuticals Inc. is ARMP and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Armata Pharmaceuticals Inc. Stock?
Armata Pharmaceuticals Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Armata Pharmaceuticals Inc. Stock?
Armata Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Armata Pharmaceuticals Inc. Stock.

What's the current price of Armata Pharmaceuticals Inc. Stock?
As of the end of day on the May 22, 2024, the price of an Armata Pharmaceuticals Inc. (ARMP) share was $2.58.

What is the 52-week high and low for Armata Pharmaceuticals Inc. Stock?
The 52-week high for Armata Pharmaceuticals Inc. Stock is $5.26 and the 52-week low is $1.07.

What is the market capitalization of Armata Pharmaceuticals Inc. Stock?
As of the May 22, 2024, the market capitalization of Armata Pharmaceuticals Inc. is 92.917M.

When is the next earnings date for Armata Pharmaceuticals Inc.?
The upcoming earnings date for Armata Pharmaceuticals Inc. is Aug 12, 2024.
Click to get the best stock tips daily for free!

About Armata Pharmaceuticals Inc.

Armata Pharmaceuticals. Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It h... ARMP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT